Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Gait disorders in multiple sclerosis.
Glia Maturation Factor Induces Interleukin-33 Release from Astrocytes: Implications for Neurodegenerative Diseases.
Corneal Sensitivity and Tear Function in Neurodegenerative Diseases.
Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis.
Voxel-based cervical spinal cord mapping of diffusion abnormalities in MS-related myelitis.
Simvastatin in patients with progressive multiple sclerosis--Authors' reply.
Requirement for interleukin-1 to drive brain inflammation reveals tissue-specific mechanisms of innate immunity.
Automated patient-specific optimization of three-dimensional double-inversion recovery magnetic resonance imaging.
Galanin is an autocrine myelin and oligodendrocyte trophic signal induced by leukemia inhibitory factor.
Cortical excitability changes over time in progressive multiple sclerosis.
[Subcutaneous immunoglobulin. Treatment in chronic inflammatory demyelinating polyradiculo-neuropathy].
[Acute transverse myelitis after allogeneic bone marrow transplantation for acute lymphoblastic leukemia--a case report].
Examination of Cognitive Fatigue in Multiple Sclerosis using Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging.
Caregiver burden, quality of life and walking ability in different disability levels of multiple sclerosis.
Adult-onset vanishing white matter disease as differential diagnosis of primary progressive multiple sclerosis: A case report.
Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial.
The glial response to intracerebrally delivered therapies for neurodegenerative disorders: is this a critical issue?
Cholinergic System Dysfunction and Neurodegenerative Diseases: Cause or Effect?
EBNA2 Binds to Genomic Intervals Associated with Multiple Sclerosis and Overlaps with Vitamin D Receptor Occupancy.
Temporal aspects of visual perception in demyelinative diseases.
Mapping of Multiple Sclerosis Walking Scale (MSWS-12) to five-dimension EuroQol (EQ-5D) health outcomes: an independent validation in a randomized control cohort.
Brain abnormalities in neuromyelitis optica spectrum disorder.
Antibody response against gastrointestinal antigens in demyelinating diseases of the central nervous system.
NMR and pattern recognition methods in metabolomics: From data acquisition to biomarker discovery: A review.
Spinal Cord Diffusion-Tensor Imaging and Motor-evoked Potentials in Multiple Sclerosis Patients: Microstructural and Functional Asymmetry.

Pages